Compounds > 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Arteriosclerosis

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Arteriosclerosis in 7 studies

*Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. [MeSH]

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, Y; Kurogi, Y; Nagao, K; Nakamura, S; Tsuda, Y; Tsutsumi, K; Yoshitsugu, H1
Tsutsumi, K; Yang, B; Yin, W; Yuan, Z1
Tsutsumi, K; Yin, W1
Inoue, Y; Iwasaki, K; Kawamura, M; Murase, T; Shima, A; Tsutsumi, K1
Chiba, T; Inoue, Y; Miura, S; Sawamura, F; Tomita, I; Tomita, T; Tsutsumi, K; Uetsuka, R1
Fukatsu, A; Hara, T; Kakumu, S; Kato, K; Kusunoki, M; Miyata, T; Nakamura, T; Nakaya, Y; Nakayama, K; Ohnaka, M; Okada, K; Sakamoto, S; Tsutsumi, K1

Reviews

1 review(s) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Arteriosclerosis

ArticleYear
Lipoprotein lipase activator NO-1886.
    Cardiovascular drug reviews, 2003,Summer, Volume: 21, Issue:2

    Topics: Animals; Arteriosclerosis; Benzamides; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Enzyme Activators; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoprotein Lipase; Lipoproteins; Organophosphorus Compounds

2003

Other Studies

6 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Arteriosclerosis

ArticleYear
Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
    Journal of medicinal chemistry, 1996, Mar-29, Volume: 39, Issue:7

    Topics: Animals; Arteriosclerosis; Benzamides; Biological Availability; Cholesterol; Chromatography, High Pressure Liquid; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Organophosphorus Compounds; Polyethylene Glycols; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triglycerides

1996
Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.
    Arzneimittel-Forschung, 2002, Volume: 52, Issue:8

    Topics: Animals; Arteriosclerosis; Benzamides; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Experimental; Eating; Enzyme Activators; Hypolipidemic Agents; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rabbits; Sucrose; Triglycerides

2002
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:1

    Topics: Adipose Tissue; Animals; Arteriosclerosis; Base Sequence; Benzamides; Cholesterol, HDL; Dose-Response Relationship, Drug; Epididymis; Lipoprotein Lipase; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Organophosphorus Compounds; Protamines; Rats; Rats, Wistar; Time Factors

1993
Antiatherogenic effects of a novel lipoprotein lipase-enhancing agent in cholesterol-fed New Zealand white rabbits.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Animals; Aorta; Aortic Diseases; Arteriosclerosis; Benzamides; Body Weight; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, Dietary; Cholesterol, HDL; Diet, Atherogenic; Glycoproteins; Hypercholesterolemia; Lipids; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rabbits; Triglycerides

1997
A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging.
    European journal of pharmacology, 1998, May-29, Volume: 350, Issue:1

    Topics: Aging; Animals; Aorta; Arteriosclerosis; Benzamides; Blood Glucose; Body Weight; Endothelium, Vascular; Enzyme Activation; Insulin; Lipid Peroxides; Lipids; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasodilation

1998
NO 1886.
    Drugs in R&D, 1999, Volume: 1, Issue:6

    Topics: Animals; Arteriosclerosis; Benzamides; Diabetic Angiopathies; Drugs, Investigational; Humans; Hypolipidemic Agents; Lipoprotein Lipase; Organophosphorus Compounds; Rabbits; Rats; Stimulation, Chemical

1999